Skip to main content
. Author manuscript; available in PMC: 2021 Jul 30.
Published in final edited form as: J Urol. 2020 Sep 10;205(2):524–531. doi: 10.1097/JU.0000000000001353

Table 2.

Characteristics of men who completed the International Consultation on Incontinence Questionnaire (ICIQ) by race/ethnicity (n=1446), 2015–2016

NH White (n=589) Chinese (n=206) NH Black (n=331) Hispanic (n=320) P value
N, (% total sample) 589 (40.7) 206 (14.3) 331 (22.9) 320 (22.1)
Age, years (SD) 74 (8.5) 73.7 (8.1) 73.3 (8.4) 73.4 (8.4) 0.5
Age Category (%) 0.08
 55–64 years 14.4 14.1 14.8 18.4
 65–74 years 40.6 40.8 47.4 38.1
 75 – 84 years 31.6 34 25.1 34.4
 ≥ 85 years 13.4 11.2 12.7 9.1
Education <0.001
 Less than High school 2.0 11.2 3.0 30.0
 High school/GED and/or some college 26.8 25.2 42.0 41.6
 College degree or higher 71.1 63.6 55.0 28.4
BMI, kg/m2 (SD) 28.3 (4.4) 24.6 (3.4) 29.1 (5.1) 29.5 (4.9) <0.001
Obese, (%) 26.8 8.2 40.2 40.3 <0.001
Impaired Fasting Glucose (%) 27.1 33 21.3 25.8 <0.001
Diabetes (%) 19.1 27.3 30.4 35.7 <0.001
General Health reported, (%) <0.001
 Excellent 22.4 3.9 9.7 10.3
 Very Good 43.6 23.8 36.2 30.6
 Good 26.7 43.2 40.8 42.5
 Fair 6.6 25.7 13 15.3
 Poor 0.7 3.4 0.3 1.2
Current smoker (%) 5.3 4.4 8.8 5.6 <0.004
1Physical activity (met-min/week) 4140 (2182, 7500) 2347 (1095, 5190) 4860 (1890, 9360) 3011 (1425, 6517)
Diuretic use (%) 16.9 7.8 24.9 14.4 <0.001
Alpha blockers use, (%) 3.2 5.4 4.3 4.7 0.5
Beta blocker use (%) 22.9 21.5 23.1 23.2 0.9
Calcium Blocker use (%) 16.9 21.9 32.2 20.7 <0.001
Prostate cancer (%) 1.1 0.5 1.6 1.8 0.6
Anticholinergics use (%) 0.7 0.5 2.4 0.6 0.05
1

Data shown as median (interquartile range)

2

Categorical data are presented as column percentages except for N (% total)